Therefore, we hypothesized that high ALKBH5 expression altered the immune microenvironment in the glioma tissues by modulating the expression levels of ICP receptors and ligands such as TNFRSF14, CD40, CD96, PDCD1LG2, CD70 and TNFSF14. The gene discussed is PDCD1LG2; the disease is central nervous system cancer.